Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer |
Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation |
Potlako intervention, Enhanced care |
Recruiting |
Long-Term Follow-Up of HPV FOCAL Participants |
HPV and cytology co-testing (via Liquid based collection device) |
Active, not recruiting |
Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients |
Placebo Administration, Physical Performance Testing, Fentanyl Citrate Buccal Tablet, Quality-of-Life Assessment, Questionnaire Administration, Morphine |
Recruiting |
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer |
Questionnaire Administration, Paclitaxel, Placebo, Nilotinib, Nilotinib Hydrochloride Monohydrate |
Recruiting |
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) |
Placebo, Sulindac 400 MG |
Recruiting |
Implementation and Effectiveness Trial of HN-STAR |
HN-STAR Intervention |
Recruiting |
Comparing Two Methods to Follow Patients With Pancreatic Cysts |
Computed Tomography, Endoscopic Ultrasound, Magnetic Resonance Imaging, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
Marker Driven Selection of Patients for Prostate Biopsy and Management |
|
Recruiting |
Cohort Study of Pancreatic Cancer Risk |
|
Active, not recruiting |